Laboratory test guide

HDL Map (with apoA-I)

Available through Boston Heart Diagnostics

For more than forty years, total circulating HDL cholesterol (HDL-C) has been used as a primary indicator of cardiovascular disease (CVD) risk. However, HDL is comprised of subpopulations of different sizes, composition and characteristics…

Compare this test’s laboratory options

HDL Map (with apoA-I)

Boston Heart Diagnostics
1 test optionFrom $249.90View tests ↓Close ↑

HDL Map (with apoA-I)

Boston Heart Diagnostics

Details

Listed markers: Apolipoprotein A-1, Blood; alpha-1 HDL; alpha-2 HDL; alpha-3 HDL; alpha-4 HDL; Pre-Beta-1 HDL

Fasting: Yes

Results should arrive 14 business days after the lab receives samples.

Not available in: HI, PR, NJ, NY, RI

Related options may differ in markers and method; confirm with your clinician. Final prices and fees are confirmed before ordering.

SpecimenPlasma
Patient price$249.90
View →

Catalog information reviewed: August 24, 2026 by the Sunridge Medical clinical team.

What this laboratory test evaluates

For more than forty years, total circulating HDL cholesterol (HDL-C) has been used as a primary indicator of cardiovascular disease (CVD) risk. However, HDL is comprised of subpopulations of different sizes, composition and characteristics that impact cardiovascular risk in drastically different ways.

Data from the Framingham Heart Study, Framingham Offspring Study, Veterans Affairs HDL Cholesterol Intervention Trial (VA-HIT) and HDL-Atherosclerosis Treatment Study (HATS) have shown that HDL subpopulations are significantly better predictors of CVD risk than HDL-C values alone.

The Boston Heart HDL Map® is the only test available that quantifies the amount of apoA-I in the five most significant subpopulations, resulting in a deeper understanding of a patient’s CVD risk. This exclusive method provides healthcare providers with an accurate and consistent indication of reverse cholesterol transport by separating the larger, cardioprotective particles most associated with decreased CVD risk from the smaller HDL particles associated with increased risk. Healthcare providers can use this information to determine the most effective treatment strategy, as well as monitor response to therapy.

Additional test information

Boston Heart’s exclusive HDL Map® test quantifies the amount of ApoA-1 in the five most significant subpopulations resulting in a deeper understanding of a patient’s CVD risk than looking at HDL-C alone. Larger particles are most associated with decreased CVD risk and the smaller particles are associated with increased risk.

Collection and processing

  • Sample type: Plasma
  • Fasting: Yes
  • Estimated laboratory processing: Results should arrive 14 business days after the lab receives samples.

How Sunridge uses laboratory information

Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.

Before requesting this test

Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.

Common questions about this laboratory test

What sample does this test require?
The listed sample type is Plasma. Confirm current collection instructions in the approved order.
Does this test require fasting?
The current catalog record lists fasting as: Yes. Follow the instructions supplied with the approved order.
How long does laboratory processing usually take?
Results should arrive 14 business days after the lab receives samples.. Timing can change after collection or if a laboratory requires additional review.

About this test

For more than forty years, total circulating HDL cholesterol (HDL-C) has been used as a primary indicator of cardiovascular disease (CVD) risk. However, HDL is comprised of subpopulations of different sizes, composition and characteristics that impact cardiovascular risk in drastically different ways.

Data from the Framingham Heart Study, Framingham Offspring Study, Veterans Affairs HDL Cholesterol Intervention Trial (VA-HIT) and HDL-Atherosclerosis Treatment Study (HATS) have shown that HDL subpopulations are significantly better predictors of CVD risk than HDL-C values alone.

The Boston Heart HDL Map® is the only test available that quantifies the amount of apoA-I in the five most significant subpopulations, resulting in a deeper understanding of a patient’s CVD risk. This exclusive method provides healthcare providers with an accurate and consistent indication of reverse cholesterol transport by separating the larger, cardioprotective particles most associated with decreased CVD risk from the smaller HDL particles associated with increased risk. Healthcare providers can use this information to determine the most effective treatment strategy, as well as monitor response to therapy.

Additional details

Boston Heart’s exclusive HDL Map® test quantifies the amount of ApoA-1 in the five most significant subpopulations resulting in a deeper understanding of a patient’s CVD risk than looking at HDL-C alone. Larger particles are most associated with decreased CVD risk and the smaller particles are associated with increased risk.

Highlighted health areas

  • Cardiovascular

Biomarkers and report focus

The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.

  • Apolipoprotein A-1, Blood
  • alpha-1 HDL
  • alpha-2 HDL
  • alpha-3 HDL
  • alpha-4 HDL
  • Pre-Beta-1 HDL

Important laboratory-testing information

This article is educational and does not diagnose a condition, establish medical care, or replace professional advice. Test availability, contents, pricing, eligibility, specimen instructions, and processing estimates can change. Sunridge must review the request and create an appropriate Fullscript order before payment. Follow the current instructions in your Fullscript account and laboratory kit, and discuss urgent or worsening symptoms with an appropriate medical professional.

Scottsdale Clinic

14200 N Northsight Blvd #160
Scottsdale, Arizona 85260

Office Hours

Monday–Friday: 9:00 AM–5:00 PM
Saturday: 9:00 AM–12:00 PM

Visit Sunridge in Scottsdale

FREE INTRODUCTORY CALL

Speak With Our Patient Care Team

Tell us what you are facing. There is no charge to speak with our Patient Care Team, understand how Sunridge works and determine whether a physician consultation may be an appropriate next step.

Call Now: 1-800-923-7878

This introductory call is not a medical consultation and does not establish a physician-patient relationship.

Have a Question or Share Feedback:
It's easy to get in touch with us